Key Highlights
- Evvy closes a $14 million Series A funding round led by Left Lane Capital. Other participants include General Catalyst, Labcorp Venture Fund, and more.
- Evvy, since its 2021 inception, focuses on data-driven innovation in women’s health, emphasizing the vaginal microbiome.
- The startup’s AI-powered vaginal healthcare platform is a pioneer, offering state-of-the-art testing, precision care, and coaching.
- Vaginal discomfort, a major health concern in the US, has high misdiagnosis and recurrence rates. Evvy aims to address this with its innovative solutions.
- The funding will enhance Evvy’s testing & care platform, leverage AI for women’s health diagnostics, and validate improved outcomes in fertility and other areas.
- Evvy introduces STI and antibiotic resistance testing as an add-on to its Vaginal Health Test.
- Priyanka Jain, Co-Founder & CEO of Evvy, envisions a future where female healthcare is data-driven, personalized, and effective.
Source: Business Wire
Notable Quotes
- “Evvy’s groundbreaking platform is changing the way we understand and care for the female body.” – Laura Sillman, VP at Left Lane Capital
- “We envision a world where the female body isn’t a medical mystery.” – Priyanka Jain, Co-Founder & CEO of Evvy
- “Evvy’s novel, comprehensive test, data-driven, personalized care, and science-backed patient education are enabling clinicians to provide women with the care they deserve.” – Dr. Leah Millheiser, Director of the Female Sexual Medicine Program at Stanford University Medical Center
SoH's Take
Evvy’s recent funding round and its innovative approach to women’s healthcare signify a transformative shift in the industry. By emphasizing data-driven solutions and leveraging AI, Evvy is addressing significant challenges in women’s health, particularly concerning the vaginal microbiome. The addition of STI and antibiotic resistance testing further showcases the company’s commitment to comprehensive care. With the support of its investors and the expertise of its leadership team, Evvy is well-positioned to lead the charge in closing the gender health gap and revolutionizing women’s healthcare.
